MicroRNA‐26a alleviates tubulointerstitial fibrosis in diabetic kidney disease by targeting PAR4
Article in Journal of Cellular and Molecular Medicine (January 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease
Article in Current Medicinal Chemistry (January 2024)
A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance
Article in Pathology - Research and Practice (April 2023)